TNL Mediagene – Ordinary Shares (NASDAQ:TNMG – Get Free Report)’s stock price rose 2.1% on Thursday . The company traded as high as $0.74 and last traded at $0.73. Approximately 236,307 shares were traded during trading, a decline of 91% from the average daily volume of 2,488,794 shares. The stock had previously closed at $0.71.
Wall Street Analyst Weigh In
Separately, Benchmark initiated coverage on shares of TNL Mediagene – Ordinary Shares in a research note on Tuesday, May 20th. They set a “speculative buy” rating and a $3.50 price target on the stock.
Get Our Latest Report on TNL Mediagene – Ordinary Shares
TNL Mediagene – Ordinary Shares Trading Up 2.1%
Institutional Inflows and Outflows
An institutional investor recently bought a new position in TNL Mediagene – Ordinary Shares stock. Mizuho Securities Co. Ltd. acquired a new position in shares of TNL Mediagene – Ordinary Shares (NASDAQ:TNMG – Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor acquired 168,298 shares of the company’s stock, valued at approximately $128,000. TNL Mediagene – Ordinary Shares accounts for about 1.5% of Mizuho Securities Co. Ltd.’s portfolio, making the stock its 21st largest position. Mizuho Securities Co. Ltd. owned 2.56% of TNL Mediagene – Ordinary Shares as of its most recent SEC filing.
TNL Mediagene – Ordinary Shares Company Profile
TNL Mediagene engages in digital advertising, integrated marketing, marketing survey, artificial intelligence technology, data analysis, content service platform, and production of audio-visual programs. It operates media, technology, and digital studio businesses primarily in Japan and Taiwan. The company was founded on May 25, 2023 and is headquartered in Taipei, Taiwan.
Recommended Stories
- Five stocks we like better than TNL Mediagene – Ordinary Shares
- How to trade using analyst ratings
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- The How And Why of Investing in Oil Stocks
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Most active stocks: Dollar volume vs share volume
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for TNL Mediagene - Ordinary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TNL Mediagene - Ordinary Shares and related companies with MarketBeat.com's FREE daily email newsletter.